Skip to main content
May 1, 1996

Stroke recurrence in patients with patent foramen ovale
The Lausanne Study

May 1996 issue
46 (5) 1301


Patent foramen ovale (PFO) is more common in patients with stroke than in matched controls, but the stroke mechanism and late prognosis are not well known. We studied features, coexisting causes, and recurrences of stroke in 140 consecutive patients (mean age 44 ± 14 years) with stroke and PFO admitted to a population-based primary-care center. We selected the patients from 340 patients (41%) aged 560 years with acute stroke. The initial event was brain infarction in 118 patients (84%) and TIA in 22 (16%). Intracranial embolic occlusions were present on angiography or transcranial Doppler in most patients admitted within 12 hours of onset, whereas a venous source was clinically apparent in only six patients (5.5%). Pulmonary embolism, Valsalva maneuver at onset, and coagulation abnormalities were rare, but one-fourth of the patients had an interatrial septum aneurysm (ISA) that coexisted with PFO. An alternative cause of stroke was present in only 22 patients (16%), usually cardiac (atrial fibrillation, severe mitral valve prolapse, akinetic left ventricular segment). During a mean follow-up of 3 years, the stroke or death rate was 2.4% per year, but only eight patients had a recurrent infarct (1.9% per year). This low rate of recurrence contrasted with the severity of initial stroke, which left disabling sequelae in one-half the patients. Multivariate analysis showed that interatrial communication, a history of recent migraine, posterior cerebral artery territory infarct, and a coexisting cause of stroke were associated with recurrence, whereas ISA and treatment type (coagulant or antiaggregant therapy, surgical closure of PFO) were not. However, given the low number of events, these findings must be taken with caution. In conclusion, our study shows that stroke associated with PFO with or without ISA is not commonly due to a coexisting cause of stroke. It is usually embolic, although a definite source cannot often be demonstrated. The presenting stroke is often severe, but recurrence is uncommon. The demonstration of factors associated with a higher risk of recurrence in subgroups of patients is critical for the long-term management of these patients.

Get full access to this article

View all available purchase options and get full access to this article.


Biller J, Adams HP Jr, Johnen MR, et al. Paradoxical cerebral embolism: eight cases. Neurology 1986;36:1356–1360.
Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke 1987;18:856–862.
Jeanrenaud X, Bogousslavsky J, Payot M, Regli F, Kappenberger L. Foramen ovale permeable et infarctus cerebral du sujet jeune. Schweiz Med Wochenschr 1990;120:823–829.
Bogousslavsky J, Cachin C, Regli F, Despland PA, Van Melle G, Kappenberger L, for the Lausanne Stroke Registry Group. Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: The Lausanne Stroke Registry. Neurology 1991;41:855–859.
Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461–465.
Bogousslavsky J. Stroke in young adults. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: pathophysiology, diagnosis, and management. New York: Churchill Livingstone, 1992:895–901.
Webster MWI, Chancellor AM, Smith HJ, et al. Patent foramen ovale in young stroke patients. Lancet 1988;2:11–12.
Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148–1152.
Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and PFO as risk factors for cryptogenic stroke in patients less than 55 years of age. Stroke 1993;24:1865–1873.
Martin R, Bogousslavsky J. Embolic versus nonembolic causes of ischemic stroke. Cerebrovasc Dis 1995;5:70–74.
Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993;119:461–465.
Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: Is stroke due to paradoxical embolism? Stroke 1993;24:31–34.
Jones HR, Caplan LR, Come PC, et al. Cerebral emboli of paradoxical origin. Ann Neurol 1983;13:314–319.
Jeanrenaud X, Kappenberger L. Patent foramen ovale and stroke of unknown origin. Cerebrovasc Dis 1991;1:184–192.
Garazi S, Bogousslavsky J, Jeanrenaud X, Van Melle G. Abnormal interatrial septum with stroke: recurrence risk and late prognosis in 103 patients [abstract]. Cerebrovasc Dis 1994;4:247.
Daniel WG. Transcatheter closure of patent foramen ovale: therapeutic overkill or elegant management for selected patients at risk? Circulation 1992;86:2013–2015.
Bridges ND, Hellensbrand W, Catson L, Filiano J, News-burger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902–1908.
Devuyst J, Jeanrenaud X, Guffi M, et al. Surgical closure of patent foramen ovale (PFO) with stroke: a pilot study [abstract]. Cerebrovasc Dis 1995;5:239.
Homma S, Di Tullio MR, Sacco RL, et al. Surgical closure of PFO in selected patients with cryptogenic stroke: a preliminary experience [abstract]. Stroke 1995;26:172.
Bogousslavsky J, Van Melle G, Regli F, for the Lausanne Stroke Registry. Analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.
Belkin RN, Kisslo J. Atrial septal aneurysm: recognition and clinical relevance. Ann Heart J 1990;120:948–957.
Schneider B, Hanrath P, Vogel P, Meinertz T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: relation to cerebrovascular events. J Am Coll Cardiol 1990;16:1000–1009.
Pearson AC, Labovitz AJ, Tatineri S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17:66–72.
Pearson AC, Nagelhout D, Castello R, Gomez C, Labovitz A. Atrial septal aneurysm and stroke: a transesophageal echo-cardiographic study. J Am Coll Cardiol 1991;18:1223–1229.
Landi G, D'Angelo A, Boccardi E, et al. Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability. Arch Neurol 1992;49:279–283.
Bogousslavsky J, Pierre P. Ischemic stroke in patients under age 45. Neurol Clin 1992;10:113–124.
Nater B, Bogousslavsky J, Regli F, Stauffer JC. Stroke patterns with atrial septal aneurysm. Cerebrovasc Dis 1992;2:342–346.
Lucas C, Leys D, Monnier-Vehier F, Henon H, Pruvo JP. Stroke patterns in patients with atrial septal aneurysm and ischemic stroke of unknown cause. Cerebrovasc Dis 1994;4:337–340.
Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782–786.
The French Study Group on Patent Foramen Ovale and Atrial Septa1 Aneurysm. Recurrent cerebrovascular events in patients with PFO or ASA and cryptogenic stroke or TIA [abstract]. Cerebrovasc Dis 1994;4:247.
Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane TEE study. Stroke 1994;25:582–586.
Anzola GP, Remaldini E, Magoni M, Costa A, Cobelli M, Guindani M. Validation of TCD sonography in the assessment of patent foramen ovale. Cerebrovasc Dis 1995;5:194–198.
Weslow RG, Di Tullio MR, Sacco RL, et al. PFO in cryptogenic stroke patients is larger than in stroke-free controls [abstract]. Stroke 1995;26:175.
Comess KA, De Rook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994;23:1598–1603.

Information & Authors


Published In

Volume 46Number 5May 1996
Pages: 1301

Publication History

Published online: May 1, 1996
Published in print: May 1996


Request permissions for this article.


Affiliations & Disclosures

For the Lausanne Stroke with Paradoxal Embolism Study Group
Department of Neurology, University Hospital, Lausanne, Switzerland (Dr. Bogousslavsky) (Dr. Garazi)
Division of Cardiology, University Hospital, Lausanne, Switzerland (Dr. Jeanrenaud) (Dr. Aebischer)
University of Social and Preventive Medicine, Lausanne, Switzerland (Dr. Van Melle)


Address correspondence and reprint requests to Dr. J. Bogousslavsky, Department of Neurology, CHUV, CH-1011 Lausanne, Switzerland.

Metrics & Citations



Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism, Neurology, 57, 7, (1330-1332), (2023)./doi/10.1212/WNL.57.7.1330
  2. Ischemic stroke and active migraine, Neurology, 57, 10, (1805-1811), (2023)./doi/10.1212/WNL.57.10.1805
  3. Adult Congenital Heart Disease, Pediatric Cardiac Surgery, (999-1054), (2023).
  4. Advances in the management of cardioembolic stroke associated with patent foramen ovale, BMJ, (e063161), (2022).
  5. Secondary Prevention of Cardioembolic Stroke, Stroke, (932-943.e4), (2022).
  6. Cryptogenic Stroke and Stroke of “Unknown Cause”, Cerebrovascular Disorders, (293-322), (2021).
  7. Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale, Journal of the American College of Cardiology, 75, 18, (2312-2320), (2020).
  8. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials, JAMA Neurology, 77, 10, (1279), (2020).
  9. Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective, Journal of Medical Economics, 22, 9, (883-890), (2019).
  10. Interatrial septum: A pictorial review of congenital and acquired pathologies and their management, Clinical Imaging, 55, (53-64), (2019).
  11. See more

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML







Share article link